3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
29
Gastrointestinal
11
Endocrine
2
Breast
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Head & Neck
1
Genitourinary
1
Dermatologic
1
CNS
1
Conditions
Multiple Myeloma
420
Lymphoma
53
Recurrence
42
Neoplasms, Plasma Cell
33
Hematologic Neoplasms
33
Immunoglobulin Light-chain Amyloidosis
29
Smoldering Multiple Myeloma
26
Lymphoma, Non-Hodgkin
25
Leukemia, Myeloid, Acute
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Hodgkin Disease
17
Myelodysplastic Syndromes
16
Monoclonal Gammopathy of Undetermined Significance
13
Waldenstrom Macroglobulinemia
11
Lymphoma, Mantle-Cell
11
Leukemia
11
Prostatic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Breast Neoplasms
10
Paraproteinemias
9
Ovarian Neoplasms
9
Lung Neoplasms
8
Leukemia, Plasma Cell
8
Amyloidosis
8
Melanoma
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Plasma cell
×
90 days
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled